Trials / Completed
CompletedNCT04842422
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream: The study is to demonstrate that Aktinic Keratosis are present before they are clinically visible, i.e. in a subclinical stage. Since on the basis of the research situation, also subclinical AK can proliferate into the dermis, it is possible that with the application of Imiquimod on chronically light-exposed skin, undetected squamous cell carcinoma can be recognized and treated at the same time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imiquimod 3.75% Cream | Imiquimod 3.75% Cream |
Timeline
- Start date
- 2021-04-16
- Primary completion
- 2021-08-23
- Completion
- 2021-08-23
- First posted
- 2021-04-13
- Last updated
- 2022-01-11
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04842422. Inclusion in this directory is not an endorsement.